November 5, 2024- November marks American Diabetes Month®, a time to raise awareness of diabetes and to support the 1.2 million Americans diagnosed with diabetes each year, and more than 38 million Americans affected by the disease. To help health care professionals enhance care and improve health outcomes for patients with diabetes, Henry Schein is offering its comprehensive range of diabetes management solutions.
Henry Schein Medical’s diabetes care offerings include capital equipment, point of care diagnostics, laboratory, hypodermic and blood collection, and pharmaceutical solutions, such as:
Pharmaceuticals: Over-the-Counter Medications andRx.
Capital Equipment: Baxter RetinaVue700 Imager and Midmark steam sterilizers and chairs.
Point of Care Diagnostics: Abbott Afinion™ 2 analyzer and Piccolo Xpressanalyzers, HemoCue® Glucose 201 System and HemoCue® Hb 801 System, Henry Schein TRUE METRIX Pro Blood Glucose Meter Kit and OneStep+ Pro Hb Analyzer, PTS Diagnostics A1CNow and CardioChek® products, Siemens DCA Vantage analyzer, and Vidan Diagnostics Lucidplus™ B-Ketone Plus Blood Glucose Monitoring System.
Laboratory: Beckman Coulter, Horiba, and Siemens chemistry and immunoassay analyzers. Tosoh Bioscience immunoassay analyzers, and Sysmex hematology analyzers.
Hypodermics and Blood Collection: Embecta products andSol-Millennium lancets.
Also available through Henry Schein Medical is Rimidi. Its remote patient monitoring solution for diabetes connects patient-generated data from connected devices like blood glucose monitors, continuous glucose monitors, and insulin pens with clinical data in electronic health record (EHR) systems. This helps give clinicians a more complete view of a patient’s health and drives patient-specific clinical insights and actions within the framework of the latest evidence and guidelines. The platform lives within the EHR—integrating seamlessly into the provider workflow. Click here for a video from Dr. Lucienne Ide, Founder and CEO of Rimidi, who highlights three trends to watch in diabetes care.
In addition to its products and solutions, this year the Henry Schein Cares Foundation, Inc. (HSCF) launched Prevention is Power™, a multi-year public health awareness campaign aimed at supporting patient adoption of a preventive, integrated health care model to improve overall health outcomes. Part of the program is to provide health care practitioners with tools to advance understanding of the connection between oral health and overall health, with one of the focus areas being diabetes and oral health. Click here for more details about Prevention is Power.
For more information about Henry Schein Medical and its diabetes care products, click here.